CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,263,029 | -20.7% | 3,465,470 | -1.9% | 1.88% | -10.0% |
| Q2 2023 | $198,327,328 | +11.0% | 3,533,357 | -11.0% | 2.09% | +1.4% |
| Q1 2023 | $178,746,255 | +9.8% | 3,972,139 | -0.9% | 2.06% | -12.2% |
| Q4 2022 | $162,863,249 | -41.2% | 4,006,476 | -6.0% | 2.35% | -33.7% |
| Q3 2022 | $277,078,000 | +0.4% | 4,262,736 | -7.0% | 3.54% | +3.8% |
| Q2 2022 | $276,054,000 | -5.2% | 4,584,098 | -0.8% | 3.41% | +59.5% |
| Q1 2022 | $291,044,000 | -11.9% | 4,619,747 | +7.0% | 2.14% | +23.0% |
| Q4 2021 | $330,526,000 | -10.3% | 4,319,471 | +31.3% | 1.74% | +9.9% |
| Q3 2021 | $368,426,000 | -32.8% | 3,289,516 | -2.8% | 1.58% | -26.3% |
| Q2 2021 | $548,120,000 | +22.9% | 3,383,456 | -7.6% | 2.15% | -1.8% |
| Q1 2021 | $445,955,000 | -24.1% | 3,659,865 | -4.6% | 2.18% | -34.5% |
| Q4 2020 | $587,456,000 | +90.3% | 3,836,823 | +3.8% | 3.34% | +21.9% |
| Q3 2020 | $308,755,000 | +14.7% | 3,697,667 | -0.4% | 2.74% | -22.4% |
| Q2 2020 | $269,118,000 | -15.8% | 3,711,970 | -50.7% | 3.53% | +17.7% |
| Q1 2020 | $319,478,000 | +72.0% | 7,533,082 | +147.0% | 3.00% | +2.4% |
| Q4 2019 | $185,733,000 | +63.1% | 3,049,553 | +9.8% | 2.92% | +44.6% |
| Q3 2019 | $113,846,000 | +29.2% | 2,777,414 | +48.4% | 2.02% | +17.0% |
| Q2 2019 | $88,143,000 | +459.5% | 1,871,408 | +324.3% | 1.73% | +316.6% |
| Q1 2019 | $15,754,000 | +60492.3% | 441,044 | +47632.0% | 0.42% | +41400.0% |
| Q4 2018 | $26,000 | -48.0% | 924 | -17.8% | 0.00% | 0.0% |
| Q3 2018 | $50,000 | – | 1,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |